SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Roche Presents New Phase Iii One-Year Data For Vamikibart In Uveitic Macular Edema

Roche Holding AG BX:RHO

RHO